Raj Mehra

Raj Mehra

Chief Executive Officer chez SEELOS THERAPEUTICS, INC.

Fortune : 109 420 $ au 31/03/2024

64 ans
Finance
Health Technology
Consumer Services

Profil

Raj Mehra is the founder of Seelos Therapeutics, Inc., where he currently serves as the President & Chief Executive Officer since 1987.
He is also the founder of Weiss, Peck & Greer LLC.
Dr. Mehra's former jobs include Chairman, President, Chief Executive Officer & CFO at Apricus Biosciences, Inc., Chairman, Chief Executive Officer & Secretary at Seelos Therapeutics, Inc., Managing Director at Auriga USA LLC, Independent Director at Larkspur Health Acquisition Corp.
from 2021 to 2022, and Head-Healthcare Equity Investments at Bennett Lawrence Management LLC.
Dr. Mehra's education includes a graduate degree, MBA, and a doctorate from The Trustees of Columbia University in The City of New York, as well as an undergraduate degree from the Indian Institute of Technology Kanpur.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/01/2024 185 143 ( 1,35% ) 109 420 $ 31/03/2024

Postes actifs de Raj Mehra

SociétésPosteDébut
SEELOS THERAPEUTICS, INC. Chief Executive Officer 01/01/2019
Tous les postes actifs de Raj Mehra

Anciens postes connus de Raj Mehra

SociétésPosteFin
LARR HEALPAR Director/Board Member -
Weiss, Peck & Greer LLC Founder -
Corporate Officer/Principal -
Chief Executive Officer -
Chief Executive Officer -
Voir l'expérience en détail de Raj Mehra

Formation de Raj Mehra

The Trustees of Columbia University in The City of New York Doctorate Degree
Indian Institute of Technology Kanpur Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Raj Mehra

Relations

18

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées7

Health Technology

Finance

Weiss, Peck & Greer LLC

Finance

Finance

Health Technology

Seelos Therapeutics, Inc.

Finance

Voir les connexions sociétés